In this video segment, three biopharma executives discuss the differences between preparing for JPM in-person versus virtual, and the pros and cons of each (e.g., using Zoom, Zoom fatigue, travel, and virtual networking receptions). This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, that […]
Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable (EVR) with In this video segment, three biopharma executives share examples of significant biopharmaceutical industry deals that have evolved out of JPM. This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, […]
Jim Woody, Ph.D., CEO, 180 Life Sciences, who has attended JPM since 2006, discusses how the show has changed over the years. This is a video segment of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, that included Woody; Terry-Ann Burrell, CFO, Beam Therapeutics; and Hunter Smith, […]